Special cells may dump fat into the lungs of people with pulmonary fibrosis, filling airspaces. Scientists at Thomas Jefferson University in Philadelphia found that decreasing the accumulation of lung fat could help reduce problems associated with this disease. Pulmonary fibrosis is characterized by scarred, thick tissue within the lungs.
Pacific Therapeutics Ltd., a pharmaceutical company focused on the reformulation of existing approved drugs, recently announced the end of an initial phase 1 trial of its drug candidate for Idiopathic Pulmonary Fibrosis, PTL-202, combined with an important antioxidant amino acid, with positive signs on its effectiveness, low side effects,…
MediciNova, a biopharmaceutical company focused on developing therapies to fulfill unmet needs in respiratory, neurological, and liver diseases, recently announced that it will present at the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF) on September 23rd in Mont Tremblant, Canada. According to a recent press release, the presentation…
Sorrento Therapeutics, Inc., a company working on the development of new treatments for cancer and its associated pain, has recently received a Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute (NHLBI), a division of the NIH, to advance its research on an immunotherapy…
Get regular updates to your inbox.
